Real-time enrollment status for this chronic kidney disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT06268873 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Chronic Kidney Disease |
| Phase | Clinical Trial |
| Target Enrollment | 2,500 participants |
| Active Locations | 129 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | January 29, 2026 (Jan 29, 2026) |
As of March 2, 2026: Clinical trial NCT06268873 is currently active_not_recruiting participants. This clinical trial study for chronic kidney disease is not currently accepting new participants at 129 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06268873 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 129 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06268873 was last updated Jan 29, 2026 (January 29, 2026). HelloStudys verifies this status automatically.